Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies
- PMID: 28817974
- DOI: 10.1080/14737159.2017.1368389
Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies
Abstract
The development of in vitro protein misfolding amplification assays for the detection and analysis of abnormally folded proteins, such as proteinase K resistant prion protein (PrPres) was a major innovation in the prion field. In prion diseases, these types of assays imitate the pathological conversion of the cellular PrP (PrPC) into a proteinase resistant associated conformer or amyloid, called PrPres. Areas covered: The most prominent protein misfolding amplification assays are the protein misfolding cyclic amplification (PMCA), which is based on sonication and the real-time quaking-induced conversion (RT-QuIC) technique based on shaking. The more recently established RT-QuIC is fully automatic and enables the monitoring of misfolded protein aggregates in real-time by using a fluorescent dye. Expert commentary: RT-QuIC is a very robust and highly reproducible test system which is applicable in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies.
Keywords: Real-time quaking-induced conversion; aggregation; prion protein; protein misfolding; sporadic Creutzfeldt-Jakob disease.
Similar articles
-
Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease.Cell Tissue Res. 2023 Apr;392(1):301-306. doi: 10.1007/s00441-022-03715-9. Epub 2022 Dec 20. Cell Tissue Res. 2023. PMID: 36536226 Free PMC article. Review.
-
Amplification and Detection of Minuscule Amounts of Misfolded Prion Protein by Using the Real-Time Quaking-Induced Conversion.Methods Mol Biol. 2018;1779:257-263. doi: 10.1007/978-1-4939-7816-8_16. Methods Mol Biol. 2018. PMID: 29886538
-
The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases.Nat Protoc. 2016 Nov;11(11):2233-2242. doi: 10.1038/nprot.2016.120. Epub 2016 Oct 13. Nat Protoc. 2016. PMID: 27735933
-
In Vitro Conversion Assays Diagnostic for Neurodegenerative Proteinopathies.J Appl Lab Med. 2020 Jan 1;5(1):142-157. doi: 10.1373/jalm.2019.029801. J Appl Lab Med. 2020. PMID: 31811072 Review.
-
Amplified Detection of Prions and Other Amyloids by RT-QuIC in Diagnostics and the Evaluation of Therapeutics and Disinfectants.Prog Mol Biol Transl Sci. 2017;150:375-388. doi: 10.1016/bs.pmbts.2017.06.003. Epub 2017 Jul 27. Prog Mol Biol Transl Sci. 2017. PMID: 28838670 Review.
Cited by
-
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.Expert Rev Mol Diagn. 2020 Apr;20(4):421-441. doi: 10.1080/14737159.2020.1731306. Epub 2020 Feb 27. Expert Rev Mol Diagn. 2020. PMID: 32066283 Free PMC article. Review.
-
Proteomic Evidence for Amyloidogenic Cross-Seeding in Fibrinaloid Microclots.Int J Mol Sci. 2024 Oct 8;25(19):10809. doi: 10.3390/ijms251910809. Int J Mol Sci. 2024. PMID: 39409138 Free PMC article.
-
Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency.Mol Neurobiol. 2020 Apr;57(4):1863-1874. doi: 10.1007/s12035-019-01837-w. Epub 2019 Dec 17. Mol Neurobiol. 2020. PMID: 31848935
-
Disease modification in Parkinsonism: obstacles and ways forward.J Neural Transm (Vienna). 2022 Sep;129(9):1133-1153. doi: 10.1007/s00702-022-02520-6. Epub 2022 Jun 13. J Neural Transm (Vienna). 2022. PMID: 35695938 Free PMC article. Review.
-
An Ex Vivo Brain Slice Culture Model of Chronic Wasting Disease: Implications for Disease Pathogenesis and Therapeutic Development.Sci Rep. 2020 May 6;10(1):7640. doi: 10.1038/s41598-020-64456-9. Sci Rep. 2020. PMID: 32376941 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials